A Multicenter, Double-blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Cytisinicline in Adult Smokers

Medicine & Life Sciences

1. Smokers 100%
2. Placebos 81%
3. Randomized Controlled Trials 79%
4. Safety 68%
5. Duration of Therapy 31%
6. Varenicline 24%
7. Health Care Outcome Assessment 22%
8. Risk Reduction Behavior 17%
9. Smoking Cessation 16%
10. Random Allocation 16%
11. Recurrence 9%
12. Therapeutics 8%